Contract Pharma

Colin MacKay, CEO of Symbiosis Pharmaceutical Services assesses the trends driving parenteral manufacturing in this article titled ‘Biotech Boom Fuels Parenteral Market’ for Contract Pharma.

Read More

Cphi Online

News about our recent appointment of an experienced Business Development Manager to support increased demand for our sterile filling services from biotech companies in the US, as featured on CPhI Online.

Read More

Outsourcing Pharma

Dr. Tom Scullion, US Business Development Manager at Symbiosis Pharmaceutical Services discusses how biotech growth is driving ‘surge in demand’ in this Q&A with Outsourcing Pharma.

Read More

Pharm Tech

Colin MacKay, CEO of Symbiosis Pharmaceutical Services discusses ‘Best Practice: Developing Drugs that are Highly Potent’ in this article for PharmTech.com.

Read More

Get In Touch.


By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.